An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

RAS mutations are among the most common drivers in cancer, particularly in pancreatic, colorectal, and lung tumors. Despite that, directly targeting RAS proteins proved extremely difficult for years, ...

Applications can be submitted anytime (24/7) through online portal at www.eservices.hec.gov.pk. In case of new user, you need to create an account by selecting the “Sign-up” option, while existing ...

CUMMINGTON — Bill Adams looks out onto what once was an artificially formed pond on Stage Road in Cummington. For years, a small culvert prevented full water flow from the North Branch Swift River, a ...

AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...

A Revolution Medicines drug helped pancreatic cancer patients live nearly six months longer compared to those treated with standard of care chemotherapy, meeting the goals of a pivotal study in this ...

Laura Schober is a writer and editor specializing in health, food, wellness, beauty, and lifestyle content. Laura is also a seasoned communications professional who has previously worked in the ...

Lasting damage to Ras Laffan Industrial City, the world’s largest liquefied natural gas export plant, would have big consequences for the global energy market. By Raja Abdulrahim Reporting from Dubai ...

Spring is a good time to mix up your routine, which has big benefits for strength and endurance — while keeping things interesting. By Hannah Singleton Say you go to the gym and pick up the same pair ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Daily showering has been treated as non‑negotiable. But according to ...

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...